Issued 2026-09-16 at $52.21 · now $52.21 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CRSP has typically landed between $40.65 and $68.16 — a range of −22.1% to +30.5% from the issuance price $52.21.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
2,469 overlapping 1 month windows · 2016-10-19 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($52.21) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CRSP has typically landed a month from the 2026-09-16 close of $52.21 — the range is history, not a prediction.
- now $52.21 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $51.24 (-1.9%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $45.71–$56.76
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $40.65–$68.16
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,469 windows spanning 2016-10-19 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-13 | −42.1% | −42.1% | +0.0% |
| 2017-01-10 | −35.7% | −35.7% | +0.0% |
| 2018-09-14 | −35.2% | −35.2% | +0.0% |
| 3 best | |||
| 2017-12-27 | +110.5% | +0.0% | +110.5% |
| 2017-12-20 | +104.0% | +0.0% | +104.0% |
| 2017-12-28 | +96.2% | +0.0% | +108.9% |
2,469 overlapping windows · 2016-10-19 – 2026-09-16 · not cherry-picked
Pending catalysts
- 2028-07-01 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension (source, as of 2026-08-14)
- January 2030 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies (source, as of 2026-08-14)
- December 2033 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~10 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Jan
60%
+7.3%
n=10
Feb
70%
+9.8%
n=10
Mar
20%
−10.5%
n=10
Apr
70%
+0.6%
n=10
May
60%
+8.7%
n=10
Jun
70%
+11.0%
n=10
Jul
70%
+2.4%
n=10
Aug
50%
+0.8%
n=10
Sep
20%
−6.0%
n=10
Oct
33%
−4.5%
n=9
Nov
70%
+17.3%
n=10
Dec
20%
−6.5%
n=10
Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Patel Naimish | director | Sale | 3,786 @ $55.62 | $211K | −16.4% of holding | −1.9% | not yet — horizon still open | 19,357 | Form 4 · filed 3 days after the trade |
| 2026-03-23 | Kulkarni Samarth | director | Sale | 10,020 @ $46.78 | $469K | −3.8% of holding | +11.8% | not yet — horizon still open | 255,501 | Form 4 · filed 1 day after the trade |
| 2026-03-23 | Prasad Raju | officer | Sale | 3,708 @ $46.78 | $173K | −19.2% of holding | +11.8% | not yet — horizon still open | 15,565 | Form 4 · filed 1 day after the trade |
| 2026-03-23 | KASINGER JAMES R. | officer | Sale | 3,182 @ $46.78 | $149K | −3.3% of holding | +11.8% | not yet — horizon still open | 94,308 | Form 4 · filed 1 day after the trade |
| 2026-03-16 | Kulkarni Samarth | director | Sale | 10,349 @ $48.26 | $499K | −4.0% of holding | +12.3% | −6.8% | 245,834 | Form 4 · filed 1 day after the trade |
| 2026-03-16 | Prasad Raju | officer | Sale | 5,848 @ $48.26 | $282K | −24.7% of holding | +12.3% | −6.8% | 17,794 | Form 4 · filed 1 day after the trade |
| 2026-03-16 | Prasad Raju | officer | Sale | 4,021 @ $48.26 | $194K | −22.6% of holding | +12.3% | −6.8% | 13,773 | Form 4 · filed 1 day after the trade |
| 2026-03-16 | KASINGER JAMES R. | officer | Sale | 3,450 @ $48.26 | $166K | −3.6% of holding | +12.3% | −6.8% | 91,240 | Form 4 · filed 1 day after the trade |
| 2026-03-16 | Patel Naimish | director | Sale | 3,150 @ $48.26 | $152K | −19.3% of holding | +12.3% | −6.8% | 13,143 | Form 4 · filed 1 day after the trade |
| 2026-03-11 | Kulkarni Samarth | director | Sale | 9,798 @ $52.80 | $517K | −4.0% of holding | +1.8% | −8.0% | 235,558 | Form 4 · filed 1 day after the trade |
| 2026-03-11 | KASINGER JAMES R. | officer | Sale | 2,800 @ $52.80 | $148K | −3.1% of holding | +1.8% | −8.0% | 87,815 | Form 4 · filed 1 day after the trade |
| 2026-02-19 | Kulkarni Samarth | director | Sale | 6,967 @ $52.58 | $366K | −3.0% of holding | −10.4% | −5.6% | 226,106 | Form 4 · filed 1 day after the trade |
| 2026-02-19 | KASINGER JAMES R. | officer | Sale | 2,112 @ $52.58 | $111K | −2.4% of holding | −10.4% | −5.6% | 85,115 | Form 4 · filed 1 day after the trade |
| 2026-01-22 | Kulkarni Samarth | director | Sale | 60,000 @ $60.23 | $3.6M | −30.9% of holding | −10.3% | −31.3% | 134,201 | Form 4 · filed same day |
| 2026-01-22 | Prasad Raju | officer | Sale | 34,972 @ $60.19 | $2.1M | −83.8% of holding | −10.3% | −31.3% | 6,767 | Form 4 · filed 4 days after the trade |
| 2026-01-20 | Kulkarni Samarth | director | Sale | 21,433 @ $51.61 | $1.1M | −9.6% of holding | +2.8% | −21.1% | 202,768 | Form 4 · filed 2 days after the trade |
| 2026-01-20 | Kulkarni Samarth | director | Sale | 8,567 @ $52.10 | $446K | −4.2% of holding | +2.8% | −21.1% | 194,201 | Form 4 · filed 2 days after the trade |
| 2026-01-06 | Prasad Raju | officer | Sale | 18,933 @ $60.18 | $1.1M | −51.9% of holding | −19.1% | −12.4% | 17,534 | Form 4 · filed 2 days after the trade |
| 2026-01-06 | Prasad Raju | officer | Sale | 5,763 @ $60.21 | $347K | −46.0% of holding | −19.1% | −12.4% | 6,767 | Form 4 · filed 2 days after the trade |
| 2026-01-06 | Prasad Raju | officer | Sale | 5,004 @ $60.00 | $300K | −28.5% of holding | −19.1% | −12.4% | 12,530 | Form 4 · filed 2 days after the trade |
| 2025-12-22 | Prasad Raju | officer | Sale | 5,472 @ $56.33 | $308K | −41.3% of holding | −4.8% | −14.6% | 7,767 | Form 4 · filed 1 day after the trade |
| 2025-12-22 | Prasad Raju | officer | Sale | 3,528 @ $55.10 | $194K | −21.0% of holding | −4.8% | −14.6% | 13,239 | Form 4 · filed 1 day after the trade |
| 2025-12-22 | Prasad Raju | officer | Sale | 1,000 @ $56.89 | $57K | −12.9% of holding | −4.8% | −14.6% | 6,767 | Form 4 · filed 1 day after the trade |
| 2025-10-17 | Kulkarni Samarth | director | Sale | 50,895 @ $67.91 | $3.5M | −16.7% of holding | −20.2% | −26.3% | 254,201 | Form 4 · filed 3 days after the trade |
| 2025-10-14 | Kulkarni Samarth | director | Sale | 4,242 @ $66.60 | $283K | −2.0% of holding | −28.0% | −26.2% | 205,096 | Form 4 · filed 1 day after the trade |
| 2025-10-14 | KASINGER JAMES R. | officer | Sale | 1,076 @ $66.60 | $72K | −1.3% of holding | −28.0% | −26.2% | 83,402 | Form 4 · filed 1 day after the trade |
| 2025-08-18 | Kulkarni Samarth | director | Sale | 13,081 @ $58.15 | $761K | −5.9% of holding | +0.1% | −14.4% | 207,004 | Form 4 · filed 1 day after the trade |
| 2025-08-06 | Treco Douglas A | director | Purchase | 20,000 @ $57.03 | $1.1M | +1000.0% of holding | −4.9% | −26.3% | 22,000 | Form 4 · filed 2 days after the trade |
| 2025-07-16 | George Simeon | director | Purchase | 960,983 @ $52.03 | $50.0M | +124.9% of holding | +3.4% | −8.1% | 1,730,179 | Form 4 · filed 1 day after the trade |
| 2025-07-16 | George Simeon | director | Purchase | 22,319 @ $52.03 | $1.2M | +10.3% of holding | +3.4% | −8.1% | 238,897 | Form 4 · filed 1 day after the trade |
| 2025-07-16 | George Simeon | director | Purchase | 6,510 @ $52.03 | $339K | +10.3% of holding | +3.4% | −8.1% | 69,687 | Form 4 · filed 1 day after the trade |
| 2025-05-29 | Patel Naimish | director | Sale | 3,932 @ $35.94 | $141K | −39.3% of holding | +27.2% | +29.1% | 6,068 | Form 4 · filed 1 day after the trade |
| 2025-04-03 | Patel Naimish | director | Purchase | 1,508 @ $32.96 | $50K | ownership Δ n/a | +10.2% | +82.0% | 1,508 | Form 4 · filed 299 days after the trade |
| 2025-03-21 | Kulkarni Samarth | director | Sale | 10,031 @ $41.23 | $414K | −4.9% of holding | +1.7% | +31.7% | 195,085 | Form 4 · filed 3 days after the trade |
| 2025-03-21 | KASINGER JAMES R. | officer | Sale | 3,185 @ $41.23 | $131K | −3.8% of holding | +1.7% | +31.7% | 81,729 | Form 4 · filed 3 days after the trade |
| 2025-03-21 | Prasad Raju | officer | Sale | 2,197 @ $41.23 | $91K | −11.6% of holding | +1.7% | +31.7% | 16,767 | Form 4 · filed 3 days after the trade |
| 2025-03-21 | Bruno Julianne | director | Sale | 1,714 @ $41.23 | $71K | −14.0% of holding | +1.7% | +31.7% | 10,544 | Form 4 · filed 3 days after the trade |
| 2025-03-17 | Prasad Raju | officer | Sale | 3,762 @ $41.80 | $157K | −22.8% of holding | −4.1% | +25.8% | 12,714 | Form 4 · filed 1 day after the trade |
| 2025-03-12 | Kulkarni Samarth | director | Sale | 4,462 @ $43.32 | $193K | −2.3% of holding | −15.4% | +10.1% | 185,428 | Form 4 · filed same day |
| 2025-03-12 | KASINGER JAMES R. | officer | Sale | 1,116 @ $43.32 | $48K | −1.4% of holding | −15.4% | +10.1% | 78,664 | Form 4 · filed same day |
| 2025-03-12 | Bruno Julianne | director | Sale | 190 @ $43.32 | $8K | −2.2% of holding | −15.4% | +10.1% | 8,508 | Form 4 · filed same day |
| 2025-03-11 | Kulkarni Samarth | director | Sale | 9,973 @ $42.42 | $423K | −5.2% of holding | −16.6% | +4.3% | 180,890 | Form 4 · filed 1 day after the trade |
| 2025-03-11 | KASINGER JAMES R. | officer | Sale | 2,850 @ $42.42 | $121K | −3.5% of holding | −16.6% | +4.3% | 77,530 | Form 4 · filed 1 day after the trade |
| 2025-03-11 | Bruno Julianne | director | Sale | 1,198 @ $42.42 | $51K | −12.7% of holding | −16.6% | +4.3% | 8,263 | Form 4 · filed 1 day after the trade |
| 2025-02-26 | Greene John | director | Purchase | 7,000 @ $44.85 | $314K | ownership Δ n/a | −10.0% | +11.2% | 7,000 | Form 4 · filed 2 days after the trade |
| 2025-02-19 | Kulkarni Samarth | director | Sale | 18,360 @ $55.20 | $1.0M | −9.7% of holding | −14.6% | −4.6% | 171,613 | Form 4 · filed 2 days after the trade |
| 2025-02-19 | Kulkarni Samarth | director | Sale | 6,928 @ $52.80 | $366K | −3.5% of holding | −14.6% | −4.6% | 189,973 | Form 4 · filed same day |
| 2025-02-19 | KASINGER JAMES R. | officer | Sale | 1,947 @ $52.80 | $103K | −2.5% of holding | −14.6% | −4.6% | 74,880 | Form 4 · filed same day |
| 2025-02-19 | Bruno Julianne | director | Sale | 333 @ $52.80 | $18K | −4.5% of holding | −14.6% | −4.6% | 7,062 | Form 4 · filed same day |
| 2025-02-18 | Kulkarni Samarth | director | Sale | 11,640 @ $55.05 | $641K | −5.6% of holding | −12.4% | −1.5% | 196,901 | Form 4 · filed 1 day after the trade |
| 2025-02-18 | KASINGER JAMES R. | officer | Sale | 9,595 @ $53.85 | $517K | −11.6% of holding | −12.4% | −1.5% | 73,002 | Form 4 · filed 1 day after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
191 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-07 | Prasad Raju | officer | Gift | 750 | 14,815 | Form 4 |
| 2026-06-05 | Treco Douglas A | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | George Simeon | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | High Katherine A | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Greene John | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Fleming Harold Edward | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Fardis Maria | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Behbahani Ali | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Rommel Christian | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Morrison Briggs | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-06-05 | Mahatme Sandesh | director | Award / grant | 13,000 | 13,000 | Form 4 |
| 2026-05-29 | KASINGER JAMES R. | officer | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-05-29 | Patel Naimish | director | Award / grant | 22,000 | 22,000 | Form 4 |
| 2026-05-29 | Prasad Raju | officer | Award / grant | 19,500 | 19,500 | Form 4 |
| 2026-05-28 | Patel Naimish | director | Option exercise | 10,000 | 20,000 | Form 4 |
| 2026-05-28 | Patel Naimish | director | Option exercise | 10,000 | 20,000 | Form 4 |
| 2026-05-28 | Patel Naimish | director | Option exercise | 10,000 | 23,143 | Form 4 |
| 2026-05-28 | Patel Naimish | director | Option exercise | 10,000 | 23,143 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Award / grant | 81,875 | 81,875 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Award / grant | 25,000 | 25,000 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Award / grant | 38,499 | 38,499 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Award / grant | 27,500 | 27,500 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Award / grant | 38,499 | 38,499 | Form 4 |
| 2026-03-20 | Patel Naimish | director | Award / grant | 30,000 | 30,000 | Form 4 |
| 2026-03-20 | Patel Naimish | director | Award / grant | 38,499 | 38,499 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Award / grant | 114,249 | 114,249 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Option exercise | 6,250 | 12,500 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Option exercise | 6,250 | 12,500 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Option exercise | 6,250 | 19,273 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Option exercise | 19,687 | 39,375 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Option exercise | 6,250 | 97,490 | Form 4 |
| 2026-03-20 | Prasad Raju | officer | Option exercise | 6,250 | 19,273 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Option exercise | 19,687 | 265,521 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Option exercise | 6,250 | 12,000 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Option exercise | 6,250 | 97,490 | Form 4 |
| 2026-03-20 | KASINGER JAMES R. | officer | Option exercise | 6,250 | 12,000 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Option exercise | 19,687 | 265,521 | Form 4 |
| 2026-03-20 | Kulkarni Samarth | director | Option exercise | 19,687 | 39,375 | Form 4 |
| 2026-03-16 | Prasad Raju | officer | Gift | 750 | 13,023 | Form 4 |
| 2026-03-14 | Prasad Raju | officer | Option exercise | 6,875 | 23,642 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.